OXACILLIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxacillin Sodium, and when can generic versions of Oxacillin Sodium launch?
Oxacillin Sodium is a drug marketed by Ani Pharms, Apothecon, Teva, Elkins Sinn, Eugia Pharma Speclts, Fresenius Kabi Usa, Hospira, Istituto Bio Ita Spa, Onesource Specialty, Piramal Critical, Sagent Pharms, Sandoz, Watson Labs Inc, and Wockhardt Bio Ag. and is included in twenty-three NDAs.
The generic ingredient in OXACILLIN SODIUM is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxacillin Sodium
A generic version of OXACILLIN SODIUM was approved as oxacillin sodium by SAGENT PHARMS on March 30th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXACILLIN SODIUM?
- What are the global sales for OXACILLIN SODIUM?
- What is Average Wholesale Price for OXACILLIN SODIUM?
Summary for OXACILLIN SODIUM
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Patent Applications: | 19 |
| DailyMed Link: | OXACILLIN SODIUM at DailyMed |
Recent Clinical Trials for OXACILLIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alphacait, LLC | Phase 2 |
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for OXACILLIN SODIUM
| Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for OXACILLIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for OXACILLIN SODIUM
US Patents and Regulatory Information for OXACILLIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 061490-006 | May 9, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Onesource Specialty | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 091486-002 | Aug 25, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs Inc | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 062856-002 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
